Consultants Forum Advertise
Subscribe
Close

  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Subscribe Now
Renew

Area Development - Site Selection, Facility Planning and Workforce Development

Johnson & Johnson Plans Montgomery County, Pennsylvania, Manufacturing Operations

02/27/2026
Global health care company Johnson & Johnson plans to establish operations in Montgomery County, Pennsylvania. The approximately $1 billion project is expected to create more than 500 jobs over twelve years.

The investment will include the construction of a new cell therapy manufacturing facility, located in Lower Gwynedd Township, which will be operated by the company’s subsidiary Janssen Biotech and will directly support the production of medicines for cancer, immune-mediated, and neurological diseases.

“For 140 years, Johnson & Johnson has been a leading innovator in American healthcare, and we are honored to continue advancing that legacy in Pennsylvania,” said Joaquin Duato, Chairman and Chief Executive Officer of Johnson & Johnson. “By uniting scientific excellence with state-of-the-art manufacturing and strategic investment, and by working collaboratively with our communities, we are delivering for patients and creating significant opportunities for workers and families.”

The project is being supported by a funding proposal from DCED for up to $12 million in tax credits through the Qualified Manufacturing Innovation and Reinvestment Deduction (QMIRD) program, up to $2 million in tax credits through the Manufacturing Tax Credit (MTC) program, a $15 million grant through the PA SITES (Pennsylvania Strategic Investments to Enhance Sites) program, and a $10 million Pennsylvania First grant.

The state has also committed to providing a Redevelopment Assistance Capital Program award of up to $2.5 million to a local community college and/or technical school to help create a workforce development training program that would serve as a talent pipeline for the company in Montgomery County. Johnson & Johnson is also receiving assistance through Pennsylvania’s Office of Transformation and Opportunity on the project via the PA Permit Fast Track Program.

“We value Johnson & Johnson’s long-time partnership here in Pennsylvania, and its decision to reinvest in Montgomery County is another huge win for the Commonwealth – further expanding our life science ecosystem, while also producing life-saving medications for people undergoing cancer treatment, ” noted Pennsylvania Department of Community & Economic Development (DCED) Secretary Rick Siger. “This announcement also sends a clear message that Pennsylvania is competing — and winning — when it comes to attracting world-class life sciences companies, growing high-quality jobs, and driving long-term economic growth across the Commonwealth. We will continue to support projects like this by making investments that keep our economic momentum going and spur our innovation economy.”

Johnson & Johnson currently operates ten facilities across Pennsylvania.

Exclusive Research